SPMO Vs. RSP: The 16-Point Lead Is Hiding A New Risk

The Invesco S&P 500 Momentum ETF (SPMO) retains a Buy rating, while the Invesco S&P 500 Equal Weight ETF (RSP) is rated Hold. Although SPMO's concentrated, technology-heavy portfolio has recently underperformed and carries elevated semiconductor and sector-concentration risk, it continues to outperform RSP over medium- and long-term periods. The recent weakness is not viewed as sufficient evidence of a durable rotation toward RSP's broader sector exposure.

Analysis

The actionable distinction is not SPMO versus RSP performance history, but factor exposure: SPMO is effectively a high-beta, crowded large-cap growth/semiconductor allocation, while RSP is a rebalance-driven size and value tilt. If AI-capex expectations remain intact, SPMO can re-rate quickly through NVDA, AVGO, MSFT and semiconductor-adjacent exposure; if earnings breadth expands, RSP should outperform as quarterly rebalancing systematically adds recent laggards and trims winners.

Near term (days to weeks), neither ETF view is a meaningful catalyst for IVZ. ETF asset flows would need to be unusually large and persistent to affect Invesco management fees or valuation; IVZ remains more sensitive to broad risk appetite, net flows across its flagship ETF complex, and operating leverage from market appreciation. Treat any product-level recommendation as unverified absent current AUM, net-flow, fee-rate, and holdings-concentration data.

For the next 1-3 months, the key relative-performance trigger is whether semiconductor earnings revisions and hyperscaler capex guidance continue to exceed expectations. A widening advance/decline line, improving small-cap relative strength, or falling concentration in the S&P 500 would favor RSP; conversely, renewed upward revisions for NVDA/AVGO and lower real yields favor SPMO. The contrarian risk is that recent momentum weakness is only a position reset, not a durable rotation: RSP's apparent diversification offers limited protection in a broad equity drawdown because its cyclical and financial exposure remains economically sensitive.

Over 6-18 months, a sustained shift toward market breadth would pressure momentum-factor returns and likely reduce the valuation premium assigned to concentrated mega-cap beneficiaries. That transition requires a real earnings handoff beyond AI-linked leaders, rather than simply a temporary sector rotation; absent that handoff, selling SPMO weakness is likely premature.

Key Decisions for Investors

• No standalone IVZ trade: the stated ETF preference has insufficient expected impact on Invesco earnings. Reassess only if disclosed Invesco ETF net flows materially accelerate for two consecutive months or management raises fee-revenue guidance.
• Use a 1-3 month relative-value expression only after confirmation: long SPMO / short RSP if semiconductor EPS revisions remain positive and the SPMO:RSP ratio recaptures its 50-day moving average; size modestly because both legs retain substantial S&P 500 beta.
• Reverse to long RSP / short SPMO if S&P 500 equal-weight relative strength breaks out while semiconductor guidance or hyperscaler capex expectations are cut. The falsifier is renewed upward AI-capex guidance and a recovery in semiconductor revision breadth.
• For existing concentrated technology exposure, avoid adding on weakness solely because of the momentum label; use NVDA and AVGO earnings, real yields, and S&P 500 market breadth as the decision gates over the next two reporting cycles.